http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0276120-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
filingDate 1988-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f62520b57e4d37e9207eb6cafc2c0f
publicationDate 1988-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0276120-A2
titleOfInvention Treatment of certain leukemias with a combination of gamma interferon and alpha interferon
abstract Human leukemia T-cells and B-cells are inhibited from proliferating by treatment with a combination of recombinant human alpha and gamma interferons, either simultaneously or sequentially, and the alpha interferon is preferably recombinant human alfa-2b interferon.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0396903-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2103623-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0396903-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2006310918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007051431-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007044893-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005037214-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2407470-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2305697-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2305698-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2305695-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2305696-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8535657-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5171567-A
priorityDate 1987-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0225759-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0087686-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0107498-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408271913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408144271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360437
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409

Total number of triples: 47.